| Subject: | FDA Issues Correction of Dosing Chart for the Tamiflu Oral Suspension for Prophylaxis of Influenza in Pediatric Patients |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Mon, 8 Jan 2007 - 12:00 am |
| Audience: Pediatric and primary care healthcare professionals and patients
Indication: Treatment of uncomplicated acute illness due to influenza infection in patients 1 year and older who have been symptomatic for no more than 2 days.
The FDA and Roche Pharmaceuticals have notified healthcare professionals of a correction to a Dear Healthcare Professional letter issued on November 13, 2006.
The original letter referenced changes to the PRECAUTIONS Section of prescribing information for... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. Currently StayAlert! is the leader in the comprehensive compliance information marketplace. Why? Because StayAlert! provides healthcare professionals with more than information. StayAlert! provides a service, in many cases "doing the work" for you, and assisting regulatory compliance officers to effectively and efficiently meet changing standards. |
|
